Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells

Cancer Immunology, Immunotherapy

Volumn 61, Issue 5, 2012, Pages 667-676

  Harashima, Nanae ^a   Inao, Tohko ^a   Imamura, Ryu ^b   Okano, Shinji ^c   Suda, Takashi ^b   Harada, Mamoru ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Akt; Apoptosis; Autophagy; Prostate cancer; TLR3

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE B; TOLL LIKE RECEPTOR 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG TARGETING; ENDOSOME; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

APOPTOSIS; AUTOPHAGY; CASPASES; CDC2 PROTEIN KINASE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ENDOSOMES; HUMANS; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POLY I-C; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYB; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862503120     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1132-1     Document Type: Article

References (45)

1. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Ann Rev Immunol 21:335-376 (Pubitemid 37174535)
2. Kelly MG, Alvero AB, Chen R et al (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66:3859-3868
3. Szczepanski MJ, Czystowska M, Szajnik M et al (2009) Triggering of toll-like receptor 4 expressed on human head and squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69:3105-3113
4. He W, Liu Q, Wang L, Chen W, Li N, Cao X (2007) TLR4 signaling promotes immune escapes of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44:2850-2859 (Pubitemid 46412506)
5. Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P (2007) Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13:4565-4574 (Pubitemid 47219727)
6. Morikawa T, Sugiyama A, Kume H et al (2007) Identification of toll-like receptor 3 as a potential therapeutic target in clear renal cell carcinoma. Clin Cancer Res 13:7503-7509
7. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006) TLR3 can direcetly rigger apoptosis in human cancer cells. J Immunol 176:4894-4901
8. Paone A, Starace D, Galli R et al (2008) Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKCα- dependent mechanism. Carcinogenesis 29:1334-1342
9. Salaun B, Zitvogel L, Asselin-Paturel C et al (2011) TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res 71:1607-1614
10. Matsumoto M, Seya T (2008) TLR3: interferon induction by double-strand RNA including poly(I:C). Adv Drug Deliv Rev 60:805-812
11. Chin AI, Miyahira AK, Covarrubias A et al (2010) Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res 70:2595-2603
12. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501 (Pubitemid 37328931)
13. Paez J, Sellers WR (2003) PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 115:145-167
14. Davey RA, Hamson CA, Healey JJ, Cunningham JM (1997) In vitro binding of purified murine ecotropic retrovirus envelop surface protein to its receptor, MCAT-1. J Virol 71:8096-8102 (Pubitemid 27446383)
15. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066 (Pubitemid 30398356)
16. Kato H, Takeuchi O, Sato S et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-115
17. Rutz M, Metzger J, Gellert T et al (2004) Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent. Eur J Immunol 34:2541-2550 (Pubitemid 39302811)
18. Bertram J, Peacock JW, Tan C et al (2006) Inhibition of the phosphatidylinositol 3′-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Res 66:4781-4788
19. Shukla S, MacLennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121:1424-1432 (Pubitemid 47328700)
20. Guan Z, Wang X, Zhu X et al (2007) Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res 67:10436-10444 (Pubitemid 350070819)
21. Muise-Hemericks RC, Grimes H, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N (1998) Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Aedepndent pathway. J Biol Chem 273:29864-29872 (Pubitemid 28510001)
22. Graff JR, Konicek BW, McNulty AM et al (2000) Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 275:24500-24505 (Pubitemid 30626543)
23. Sharma M, Chuang WW, Sun Z (2002) Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3β inhibition and nuclear β-catenin accumulation. J Biol Chem 277: 30935-30941 (Pubitemid 34970795)
24. Ogawara Y, Kishishita S, Obata T et al (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 277:21843-21850 (Pubitemid 34952337)
25. Thakkar H, Chen X, Tyan F et al (2001) Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance. J Biol Chem 276:38361-38369
26. Shankar S, Chen Q, Ganapathy S, Singh KP, Srivastava RK (2008) Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms. Mol Cancer Ther 7:2328-2338
27. She QB, Ye SQ, O'Reilly KE, Lobo J, Rosen N (2005) The BAD protein intergrates survival signaling by EGFR/MAPK and PI3K/ Akt kinase pathway in PTEN-deficient tumor cells. Cancer Cell 8:287-297 (Pubitemid 41443414)
28. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of diseases. Cell 132:27-42
29. Kabeya Y, Mizushima N, Ueno T et al (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720-5728
30. Kim PK, Hailey DW, Mullen RT, Lippincott-Schwartz J (2008) Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc Natl Acad Sci 105:20567-20574
31. González-Reyes S, Fernández JM, González LO et al (2011) Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother 60:217-226
32. Gall R, Starace D, Busa et al (2010) TLR stimulation of prostate tumor cells induces chemkine-mediated recruitment of specific immune cell types. J Immunol 184:6658-6669
33. Ilvesaro JM, Merrell MA, Swain TM et al (2007) Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 67:774-781 (Pubitemid 46709446)
34. Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW (2006) Transforming acidic coiled ciol 1 promotes transformation and mammary tumorigenesis. Cancer Res 65:10363-10370 (Pubitemid 41743729)
35. Majumder PK, Sellers WR (2005) Akt-regulated pathways in prostate cancer. Oncogene 24:7465-7474 (Pubitemid 41637986)
36. Malik SN, Brattain M, Ghosh PM et al (2002) Immunohistochemical demonstration of phosphor-Akt in high Gleason grade prostate cancer. Clin Can Res 8:1168-1171 (Pubitemid 35177371)
37. Kreisberg JI, Malik SN, Prihoda TJ et al (2004) Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical out come in prostate cancer. Can Res 64:5232-5236 (Pubitemid 39006542)
38. Ayala G, Thompson T, Yang G et al (2004) High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res 10:6572-6578 (Pubitemid 39346553)
39. Sarkar S, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC (2004) Novel roles of TLRs tyrosine phosphorylation and PI3 kinase in double-strand RNA signaling. Nat Struct Mol Biol 11:1060-1067 (Pubitemid 39453334)
40. Tang DG, Li L, Chopra DP, Porter AT (1998) Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res 58:3466-3479 (Pubitemid 28371092)
41. Ghafar MA, Anastasiadis AG, Chen MW et al (2003) Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 54:58-67 (Pubitemid 36043837)
42. Gewirtz DA (2009) Autophagy, senescence and tumor dormancy in cancer therapy. Autophagy 5:1232-1234
43. Hähnel P, Thaler S, Antunes E, Huber C, Theobald M, Schuler M (2008) Targeting AKT signaling sensitizes cancer to cellular immunotherapy. Cancer Res 68:3899-3906
44. Tormo D, Checinska A, Alonso-Curbelo D et al (2009) Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 16: 103-114
45. Besch R, Poeck H, Hohenauer T et al (2009) Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest 119:2399-2411